Otsuka Holdings Co., Ltd. (FRA:OS1)

Market Cap	26.06B
Revenue (ttm)	14.17B
Net Income (ttm)	2.41B
Shares Out	n/a
EPS (ttm)	4.50
PE Ratio	10.80
Forward PE	n/a
Dividend	0.78 (1.64%)
Ex-Dividend Date	Jun 27, 2025

Volume	n/a
Average Volume	33
Open	48.80
Previous Close	48.80
Day's Range	48.40 - 48.80
52-Week Range	37.60 - 59.00
Beta	n/a
RSI	66.54
Earnings Date	Oct 31, 2025

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 35,338
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OS1

Financial Performance

In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.

Financial numbers in JPY